Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Top Cited Papers
Open Access
- 28 April 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (16), 1582-1589
- https://doi.org/10.1001/jama.2020.4783
Abstract
The epidemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originating in Wuhan, China, has rapidly spread worldwide.1 As of March 24, 2020, China had reported 81 767 cases with 3281 deaths, and the World Health Organization declared coronavirus disease 2019 (COVID-19) a pandemic. As of March 18, 2020, cases were reported in approximately 195 countries.2Keywords
This publication has 22 references indexed in Scilit:
- Evaluation of Convalescent Plasma for Ebola Virus Disease in GuineaThe New England Journal of Medicine, 2016
- Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus DiseaseClinical Infectious Diseases, 2015
- The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United StatesClinical Infectious Diseases, 2015
- Assessment of PaO2/FiO2 for stratification of patients with moderate and severe acute respiratory distress syndromeBMJ Open, 2015
- The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysisThe Journal of Infectious Diseases, 2014
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus InfectionClinical Infectious Diseases, 2011
- Treatment with Convalescent Plasma for Influenza A (H5N1) InfectionThe New England Journal of Medicine, 2007
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNature Medicine, 2006
- Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospitalJournal of Antimicrobial Chemotherapy, 2005
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004